Dominik J Schaer
Overview
Explore the profile of Dominik J Schaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
3173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akeret K, Thomson B, Ghosh S, Nolte M, Fischer U, Humar R, et al.
Fluids Barriers CNS
. 2024 Nov;
21(1):91.
PMID: 39548489
Background: Preclinical studies indicate that the systemic application of C1-inhibitor, clinically used to treat hereditary angioedema, reduces secondary brain injury after ischemic stroke. This study assessed the effect of C1-inhibitor...
2.
Schmid-Mohler G, Hubsch C, Braun J, Steurer-Stey C, Aregger C, Schaer D, et al.
Chron Respir Dis
. 2024 Oct;
21:14799731241291067.
PMID: 39407408
Objective: To explore the feasibility and effect of a nurse-led integrated care intervention on health-related quality of life (QoL) and unplanned 90-day rehospitalisation in patients hospitalised due to acute exacerbation...
3.
Schaer D, Schaer C, Humar R, Vallelian F, Henderson R, Tanaka K, et al.
Anesthesiology
. 2024 Aug;
141(6):1162-1174.
PMID: 39159287
No abstract available.
4.
Thomson B, Schwendinger N, Beckmann K, Gentinetta T, Couto D, Wymann S, et al.
Transl Stroke Res
. 2024 Apr;
PMID: 38652234
Secondary brain injury (SBI) occurs with a lag of several days post-bleeding in patients with aneurysmal subarachnoid hemorrhage (aSAH) and is a strong contributor to mortality and long-term morbidity. aSAH-SBI...
5.
Schaer D, Schulthess-Lutz N, Baselgia L, Hansen K, Buzzi R, Humar R, et al.
J Clin Invest
. 2023 Dec;
134(3).
PMID: 38060331
Microscopic hemorrhage is a common aspect of cancers, yet its potential role as an independent factor influencing both cancer progression and therapeutic response is largely ignored. Recognizing the essential function...
6.
Thomson B, Gurlek F, Buzzi R, Schwendinger N, Keller E, Regli L, et al.
J Stroke Cerebrovasc Dis
. 2023 Sep;
32(11):107357.
PMID: 37734180
Objectives: Cerebrospinal fluid hemoglobin has been positioned as a potential biomarker and drug target for aneurysmal subarachnoid hemorrhage-related secondary brain injury (SAH-SBI). The maximum amount of hemoglobin, which may be...
7.
Galea I, Bandyopadhyay S, Bulters D, Humar R, Hugelshofer M, Schaer D
Stroke
. 2023 May;
54(7):1930-1942.
PMID: 37232189
Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating form of stroke frequently affecting young to middle-aged adults, with an unmet need to improve outcome. This special report focusses on the development...
8.
De Godoi Rezende Costa Molino C, Woll L, Wieczorek M, Abderhalden L, Lanz P, Schaer D, et al.
Am J Clin Nutr
. 2023 Feb;
117(1):12-21.
PMID: 36789930
Background: Iron deficiency (ID) is associated with negative health outcomes in older adults. However, data on the impact of ID on the number of hospitalizations and length of hospital stay...
9.
Thomson B, Richter H, Akeret K, Buzzi R, Anagnostakou V, van Niftrik C, et al.
J Stroke Cerebrovasc Dis
. 2023 Jan;
32(3):106985.
PMID: 36640721
Objectives: Cell-free hemoglobin in the cerebrospinal fluid (CSF-Hb) may be one of the main drivers of secondary brain injury after aneurysmal subarachnoid hemorrhage (aSAH). Haptoglobin scavenging of CSF-Hb has been...
10.
Emmenegger M, De Cecco E, Lamparter D, Jacquat R, Riou J, Menges D, et al.
iScience
. 2023 Jan;
26(2):105928.
PMID: 36619367
Effective public health measures against SARS-CoV-2 require granular knowledge of population-level immune responses. We developed a Tripartite Automated Blood Immunoassay (TRABI) to assess the IgG response against three SARS-CoV-2 proteins....